Shanghai Pharmaceuticals Holding Co Ltd
HKEX:2607
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Shanghai Pharmaceuticals Holding Co Ltd
HKEX:2607
|
CN |
|
L
|
Lee & Man Paper Manufacturing Ltd
OTC:LMPMF
|
HK |
|
Asia Vital Components Co Ltd
TWSE:3017
|
TW |
|
Canada Nickel Company Inc
XTSX:CNC
|
CA |
|
Vranken Pommery Monopole SA
LSE:0J7D
|
FR |
|
M
|
Marathon Petroleum Corp
F:MPN
|
US |
|
P
|
Phoenix Mecano AG
XBER:PXM
|
CH |
Wall St Price Targets
Price Targets Summary
Shanghai Pharmaceuticals Holding Co Ltd
According to Wall Street analysts, the average 1-year price target for Shanghai Pharmaceuticals Holding Co Ltd is 14.85 HKD with a low forecast of 8.97 HKD and a high forecast of 19.3 HKD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Shanghai Pharmaceuticals Holding Co Ltd's stock price target?
Price Target
14.85
HKD
According to Wall Street analysts, the average 1-year price target for Shanghai Pharmaceuticals Holding Co Ltd is 14.85 HKD with a low forecast of 8.97 HKD and a high forecast of 19.3 HKD.
What is the Revenue forecast for Shanghai Pharmaceuticals Holding Co Ltd?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 7%.
What is the Operating Income forecast for Shanghai Pharmaceuticals Holding Co Ltd?
Projected CAGR
8%
Over the last 14 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 3 years is 8%.
What is the Net Income forecast for Shanghai Pharmaceuticals Holding Co Ltd?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 3 years is 5%.
